USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/11003
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLacusta, Alina-
dc.date.accessioned2020-07-06T11:57:56Z-
dc.date.available2020-07-06T11:57:56Z-
dc.date.issued2018-
dc.identifier.citationLACUSTA, Alina. Breathe new life into chronic kidney disease. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 182-183.en_US
dc.identifier.urihttps://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/11003-
dc.descriptionDepartment of pathophysiology and clinical pathophysiology, Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldovaen_US
dc.description.abstractIntroduction. Chronic kidney disease (CKD) is a worldwide public problem. There is a rising incidence and prevalence of kidney failure with poor outcomes and high cost. The guidelines define CKD as kidney damage or decreased glomerular filtration rate (GFR) less than 60 mL/min/1.73m2 for at least 3 months. In Moldova, there were registered 490 patients with chronic kidney disease in 2017. Nowadays, dialysis and transplantation are 2 main solutions especially in end-stage kidney disease. Dialysis will prolong the life, but they will not have a normal life quality. Life expectancy of someone on dialysis is lower than that of the general population. Dialysis and transplantation are not fully available for all patients. Aim of the study. Analysis and comparing the data of latest studies performed in Europe and USA regarding new approach of CKD treatment, including exploring the field of artificial kidney grown in laboratories. Materials and methods. The principle of this study execution consists on exploring of different new and suitable methods of treatment and life quality improvement in patients with CKD. Meta-analysis of diverse studies is the key tool for disclosure of optimal strategies for kidney function improvement in the ends stage of diseases. Results. 1. Regenerative medicine holds the potential to fully heal damaged tissues and organs, offering solutions and hope for people who have conditions that today are beyond repair. 2. A new drug therapy that could potentially control protein leakage from the kidneys. 3. A new approach to prevent the kidney cell irreversible injury: AC1903. 4. Scientists have successfully produced human kidney tissue within a living organism, which is able to produce urine. Conclusions. The outcome of the study reveals a significant "win" on kidney disease. In Moldova patients reach late stages of chronic renal disease, because a lot them are addressing too late to medical care services. That’s why new treatment methods have a great importance to save lives of patients with CKD and to improve their life quality as well.en_US
dc.language.isoenen_US
dc.publisherMedEsperaen_US
dc.subjectChronic kidney disease (CKD)en_US
dc.subjectchronic renal failureen_US
dc.subjecttherapeutic methodsen_US
dc.titleBreathe new life into chronic kidney diseaseen_US
dc.typeArticleen_US
Appears in Collections:MedEspera 2018

Files in This Item:
File Description SizeFormat 
Lacusta_Alina.pdf505.73 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback